KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $5,835,000 | +85.6% | 32,451 | +7.0% | 0.02% | +90.9% |
| Q2 2017 | $3,144,000 | +68.8% | 30,331 | +27.8% | 0.01% | +57.1% |
| Q1 2017 | $1,863,000 | +84.5% | 23,731 | +5.3% | 0.01% | +75.0% |
| Q4 2016 | $1,010,000 | -99.9% | 22,533 | -0.3% | 0.00% | -20.0% |
| Q3 2016 | $1,261,989,000 | +11.9% | 22,592 | +0.2% | 0.01% | 0.0% |
| Q2 2016 | $1,127,900,000 | +44.2% | 22,558 | +32.4% | 0.01% | +66.7% |
| Q1 2016 | $782,000,000 | -25.5% | 17,040 | 0.0% | 0.00% | -25.0% |
| Q4 2015 | $1,050,000,000 | +95094.9% | 17,040 | -14.0% | 0.00% | -20.0% |
| Q3 2015 | $1,103,000 | -99.9% | 19,809 | +0.0% | 0.01% | 0.0% |
| Q2 2015 | $1,207,267,000 | +137.1% | 19,801 | +124.3% | 0.01% | +150.0% |
| Q1 2015 | $509,084,000 | -1.1% | 8,826 | -1.2% | 0.00% | 0.0% |
| Q4 2014 | $514,993,000 | – | 8,930 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,410,034 | $433,348,000 | 77.71% |
| COWEN INC. | 4,200,600 | $755,310,000 | 26.72% |
| Tyrus Capital S.A.M. | 1,314,812 | $236,416,000 | 18.49% |
| OMNI PARTNERS LLP | 661,711 | $118,982,000 | 15.19% |
| FNY Partners Fund LP | 379,510 | $68,239,000 | 11.61% |
| EQUITEC PROPRIETARY MARKETS, LLC | 240,100 | $43,172,000 | 10.15% |
| EQUITEC PROPRIETARY MARKETS, LLC | 227,500 | $40,907,000 | 9.62% |
| GARDNER LEWIS ASSET MANAGEMENT L P | 773,817 | $139,140,000 | 8.89% |
| Quad Capital Management Advisors LLC | 192,537 | $34,620,000 | 7.10% |
| Avoro Capital Advisors LLC | 496,983 | $89,363,000 | 6.93% |